Matrix metalloproteinases and endometriosis
- PMID: 12917785
- DOI: 10.1055/s-2003-41322
Matrix metalloproteinases and endometriosis
Abstract
Retrograde menstruation represents a plausible explanation for the development of most cases of endometriosis; nevertheless, additional factors must contribute to the development of disease in only 10 to 20% of women. The discriminating factor(s) in determining the development of active endometriosis probably involves a complex array of potentially interactive influences including steroid exposure, immunological disturbances, genetic predisposition, and, perhaps, environmental toxin exposure. Matrix metalloproteinases (MMPs), enzymes that mediate normal tissue turnover including endometrial breakdown at menstruation, appear to be involved in the invasive establishment of the disease. In addition, several MMPs appear to be inappropriately expressed in the endometrium of women with this disease in association with a reduced sensitivity to progesterone. Altered regulation of endometrial MMP expression in response to steroids may represent a mechanism linking the invasive potential of refluxed endometrium to the establishment of this disease only in certain women.
Similar articles
-
[Matrix metalloproteinases and their role in menstruation and endometriosis].Zentralbl Gynakol. 2005 Oct;127(5):320-4. doi: 10.1055/s-2005-836864. Zentralbl Gynakol. 2005. PMID: 16195977 Review. German.
-
The role of matrix metalloproteinases in the pathogenesis of endometriosis.Reprod Sci. 2009 Aug;16(8):717-26. doi: 10.1177/1933719109333661. Epub 2009 Apr 7. Reprod Sci. 2009. PMID: 19351962 Review.
-
Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis.Fertil Steril. 2005 Mar;83(3):529-37. doi: 10.1016/j.fertnstert.2004.11.026. Fertil Steril. 2005. PMID: 15749474 Review.
-
Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.Am J Reprod Immunol. 2006 Sep;56(3):201-14. doi: 10.1111/j.1600-0897.2006.00418.x. Am J Reprod Immunol. 2006. PMID: 16911716
-
Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis.Ann N Y Acad Sci. 2002 Mar;955:37-47; discussion 86-8, 396-406. doi: 10.1111/j.1749-6632.2002.tb02764.x. Ann N Y Acad Sci. 2002. PMID: 11949963
Cited by
-
TIMP1 contributes to ovarian anomalies in both an MMP-dependent and -independent manner in a rat model.Biol Reprod. 2012 Feb 29;86(2):47. doi: 10.1095/biolreprod.111.094680. Print 2012 Feb. Biol Reprod. 2012. PMID: 22053095 Free PMC article.
-
Novel therapies targeting endometriosis.Reprod Sci. 2011 Sep;18(9):814-23. doi: 10.1177/1933719111410713. Epub 2011 Jun 21. Reprod Sci. 2011. PMID: 21693775 Free PMC article. Review.
-
Cellular and molecular basis for endometriosis-associated infertility.Cell Tissue Res. 2012 Sep;349(3):849-62. doi: 10.1007/s00441-011-1309-0. Cell Tissue Res. 2012. PMID: 22298022 Free PMC article. Review.
-
Matrix metalloproteinases 3 polymorphism increases the risk of developing advanced endometriosis and infertility: A case-control study.Eur J Obstet Gynecol Reprod Biol X. 2019 May 6;3:100041. doi: 10.1016/j.eurox.2019.100041. eCollection 2019 Jul. Eur J Obstet Gynecol Reprod Biol X. 2019. PMID: 31404425 Free PMC article.
-
NK Cells as Potential Targets for Immunotherapy in Endometriosis.J Clin Med. 2019 Sep 14;8(9):1468. doi: 10.3390/jcm8091468. J Clin Med. 2019. PMID: 31540116 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical